Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07271238Not ApplicableRecruiting

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

Role: lead

NCT07210151Not ApplicableRecruiting

Anatomical Navigation for Guided Electrophysiology in AFL and AFib

Role: lead

NCT06293430Not Yet Recruiting

Registry on Luma Vision's VERAFEYE System (ENLIgHT)

Role: lead

NCT06895187Not Yet Recruiting

Catheter Ablation Using a Novel Navigation and Imaging System

Role: lead

NCT05931835Not ApplicableCompleted

Feasibility Study on the VERAFEYE System

Role: lead

All 5 trials loaded